Although effective in maintaining relatively normal levels of blood pressure in hypertensive patients and retarding some of the serious and fatal secondary consequences of the disease, hexamethonium ion and 1-hydrazinophthalazine can cause severe immediate and late reactions. The latter drug has produced collagen diseases of varying degrees of severity, all of which have regressed on cessation of medication, in 14 of 253 patients. The combination has given rise to fatal interstitial pneumonia in 5 of 89 in malignant stages of hypertension. Less serious side effects of each agent are also discussed.
T HE combination of 1-hydrazinophthalazine and hexamethonium chloride has been used in the treatment of over 250 patients with hypertension for periods up to 25 months.' Reduction of the arterial pressure has been achieved and maintained in all with reversal of secondary effects of hypertension in a majority. Continuous administration has been required; therefore, a critical analysis of untoward reaction to these drugs is necessary to evaluate their ultimate usefulness. Reactions have been seen which seem clearly attributable to one or the other agent alone, while a few persons have exhibited an unusual response only in the presence of combined therapy.
SIDE EFFECTS OF HEXAMETHONIUM ION
Hexamethonium salts in the doses employed produce a partial blockade of variable degree of all autonomic ganglia. This action leads to inhibition of many autonomic functions not concerned with reduction of pressure. Although these disturbances represent direct actions of Hyphex is a contraction of the words hydrazinophthalazine and hexamethonium, used for convenience in describing the method.
Dr. Perry is a Life Insurance Medical Research Fellow. 829 the drug, they must be considered "side effects." No specific sensitivities or idiosyncrasies have been encountered which were caused by hexamethonium salts. The bromide salt, used sparingly, has not led to bromidism. Orthostatic hypotension was measurable in every case but was usually asymptomatic and decreased or disappeared with time. In patients who had previously undergone surgical sympathectomy postural fall in pressure was exaggerated and has usually required that a compromise be made in dosage in order that weakness or syncope not occur on standing. One case, R. W., a 40 year old man exhibited a systolic drop of 100 mm. Hg and a diastolic of 60 between the supine and erect positions.
Constipation was the most troublesome complication of oral hexamethonium therapy. Suppression of intestinal motility was observed in every case; two individuals with chronic colitis were relieved of excessive frequency of stools. One noticed alternating periods of constipation and diarrhea which could not be related to laxatives or intestinal abnormality. In one, diarrhea through a canalized impaction of feces in the sigmoid colon was discovered. Constipation progressing to adynamic ileus has been seen on several occasions when inadequate attention has been given the bowel; the ileus has been reversible except when associated with organic intestinal disease (table 2) .
Absorption of hexamethonium is probably altered by intestinal motility, for effects are Circulation, Volunme VIJI, December, 1953 increased with constipation and lessened with diarrhea. For example, a 47 year old Negro woman with hypertension and nitrogen retention had been on combined therapy for four months during which time she had been severely constipated. She was admitted to the hospital with a paralytic ileus; the serum hexamethonium concentration was found to be 1 1.8 mg. per 100 cc. After 72 hours in the hospital without further drug therapy and before intestinal motility had been restored the level had risen to 16 mg. per 100 cc. Return of normal bowel function was followed by a prompt fall of the serum levels to normal (0.3 to 1.0 per cent). It seemed clear that the constipation in this case had led to the accumulation of a large pool of hexamethonium chloride in the gut which permitted the serum level to rise without further ingestion and despite These were corrected by suitable lenises. Hypotonicity of the bladder was common but transient unless associated with obstruction (table 2) . Decreased potency or impotence in males was constant in early stages but complete or partial recovery has been noted in many. This disturbance caused one man to discontinue therapy. No comparable chaniges were noticed by women.
In the presence of partial asymptomatic organic obstruction of a hollow organ, further serious obstruction has been enfouniitered following the use of hexamethonium chloride (table 2) . Prostatic obstruction has been the most frequent condition, necessitating operative interference on four occasions. Nonsuppurative otitis media has been seen inl nine cases; in three, myringotomy released clear, sterile, serous exudate. The mechanism is obscure but 
SIDE EFFECTS OF 1-HYDRAZINOPnTIIALAZINE Minor Reactions. 1-Hydrazinophthalazine (Apresoline) is an antihistaminase in vitro;
the side effects which attend its use are best Symptoms explained by the liberation of histamine. Stuffy nose, periorbital edema, lacrimation, slight but diffuse edema, headache, generalized aching and prostration were seen in a majority of patients on initiation of therapy but varied greatly in severity. A diencephalic flush similar to that induced by intracutaneous histamine was also common. The response was always self-limited and the course possibly shortened by antihistaminic drugs. All of these symptoms exhibited severe calcific aortic stenosis. In nine other patients with angina, however, in whom a longer trial of a combination of hexamethonium and hydrazinophthalazine (Hyphex) was possible, one was partially and seven were completely relieved, while one voluntarily stopped treatment before significant change in blood pressure was obtained. One woman who had had previous admissions to hospital for neurodermatitis suffered a severe 
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Incidence (per cent) ............ 9.7 were milder and of shorter duration when Apresoline was used in combination with hexamethonium chloride than when Apresoline was used alone.' Table 3 lists the various symptoms and the treatment utilized for their control.
Serious Reactions. In nine patients immediate serious reactions occurred. In two subjects with angina pectoris Apresoline definitely caused increase in anginal pain and was discontinued after only a few doses. One of these exacerbation of her skin eruption and therapy was stopped.
In six instances a severe febrile reaction followed the administration of Apresoline, occurring from two days to three weeks after beginning therapy. After discontinuation for several days the drug again caused abrupt febrile responses. In two women it was possible to continue the medication after one or more episodes of fever. One young woman was able to take 4-methyl 1-hydrazinophthalazine (Ba- 6130), a chemical analogue of Apresoline, without fever, but later discontinued all therapy because of lack of cooperation. In three women it has been impossible to use Apresoline, and two of these have shown a sensitivity to one or more of the analogues of Apresoline. There of treatment which was indistinguishable from acute rheumatoid arthritis at first and, if Apresoline was continued, disseminated lupus erythematosis (7.2 per cent). The incidence is increasing. It was clearly delineated from hexamethonium intoxication, both acute, with Discontinued due to lack of cooperation was no consistent history of previous allergic diseases. All but one of those exhibiting severe fever have been women (table 4) .
Collagen Disease. Several patients have noticed transient arthralgia disappearing without treatment or cessation of Apresoline. In 16 a syndrome developed after 4 to 23 months complete autonomic blockade and high drug serum level, and chronic, with interstitial pneumonia (see below). It was less well differentiated from the pyrexia occurring three days to three weeks after the initiation of hydrazinophthalazine therapy. In our experience the patients who had the most marked immediate In no case was the diastolic blood pressure over 90 mm. Hg at the onset of the initial symptoms. Arthritis was always prominent. Often it was multiple and frequently involved the distal portions of the upper extremity. of less than 4 million cells per cubic millimeter occurred in 5 and leukopenia of less than 3,500 cells per cubic millimeter in 4 persons of 11.
Adenopathy and splenomegaly appeared in 4 patients of 13. Hyperglobulinemia of more than 2.5 Gm. per 100 cc. was present 5 times in 9 and albuminuria of a trace or more 5 times in Note: An additional case occurred in a white man, age 55, with malignant hypertension, cardiac decompensa tion but adequate renal function. Two months after beginning therapy he developed pneumonia and died enroute to hospital. Autopsy revealed interstitial pneumonia. Two others in malignant stages with uremia died after discontinuation of Hyphex. Upon careful re-examination of sections both showed minimal signs of interstitial pneumonia.
Various skin rashes occurred in five patients. Hepatitis, demonstrated by abnormal cephalincholesterol flocculation, thymol turbidity, and/ or hepatomegaly, appeared in 11 of 12 instances. Pyrexia over 37.5 C. was noted in 9 of 13 cases and in 3 was over 39 degrees. There was microscopic hematuria in 7 of 11 patients and in 2 the urine was grossly bloody. Anemia 11. Only one individual had all of these abnormalities, although three others had sufficient findings to suggest the diagnosis of lupus erythematosis; "L-E" cells were not found. Regression to or toward normal invariably followed cessation of the drug. In four, the arthritis was shown to be directly related to the administration of Apresoline, in that several --isolated single doses caused recurrences of high fever and acute polyarthritis after symptoms had subsided. Cortisone given to four patients relieved the arthritis rapidly. The following three cases illustrate this condition.
Case No. 1. T. P., a 56 year old white banker, first became slightly hypertensive in 1945 at the age of 48. He had suffered from vasomotor rhinitis for several years. Each year thereafter his blood pressure rose slightly until by October 1948 his systolic was 182 mm. Hg and his diastolic 114 mm. at which levels it remained. In January 1949 he suffered an attack of acute malignant hypertension with nitrogen retention and grade IV ocular fundi, which redressed with rest in bed but recurred in April. Bilateral lumbodorsal sympathectomy was performed which was successful only for 20 months.
In December 1950 he experienced another attack of malignant hypertension which was reversed by Apresoline; again in March and in May, 1951 ocular fundi altered and diastolic pressure became very high. Increased doses of Apresoline appeared to cause reversal of the stage. He was started on hexamethonium chloride in September 1951 because of rising blood pressure, and achieved fairly good control (therapeutic grade 11).
He continued to do well until July, 1952, when he became ill. He showed fever, hepato-and splenomegaly, leukopenia, slight anemia, albuminuria and microscopic hematuria. These signs regressed slowly until in October arthralgia developed in his wrists and hands with objective joint changes consistent with rheumatoid arthritis. A brief course of cortisone relieved his symptoms and he felt well until November 1952, when he was hospitalized elsewhere for what was believed to be hepatitis. Returning to St. Louis, he was found to have an enlarged liver and spleen with no jaundice. Urine revealed a few red blood cells and there was slight anemia. Retrograde pyelograms were normal. In December the nonprotein nitrogen in his blood was elevated for the first time since 1948. There was a trace of albumin and many red blood cells in his urine. Anemia had progressed but examination showed normally cellular bone marrow. He had lost 20 pounds in weight. Repeated transfusions failed to control the anemia. There was no eosinophilia, and the Hargraves test for "L-E" cells was negative on three occasions. He was normotensive. Intermittent fever as high as 39.3 C. was present, with 3,400 white blood cells and 3.1 million red blood cells per cubic millimeter. Cephalin-cholesterol flocculation was 4 plus, thymol turbidity 11.0 units. Nonprotein nitrogen in the blood was 54 mg. per 100 cc., albumin 3.8 and globulin 2.9 Gm. per 100 cc. Treatment consisted of discontinuation of Apresoline and the administration of massive doses of cortisone which have been continued to the present. This regimen resulted in improved sense of well being, shrinking of the liver and spleen, decrease in the nitrogen retention and control of the anemia, but there was a moderate rise in blood pressure partially controlled by increased doses of hexamethonium chloride. . Reduction of the dose of Apresoline (5968) was made more rapidly than the hypertensive process had regressed, and blood pressure rose. An attempt to control the rise by increased doses of hexamethonium chloride (C6) failed; only when those of Apresoline were doubled did blood pressure return toward normal levels. These alterations in dosage of Apresoline were made voluntarily by the patient, while those of hexamethonium ion were imposed by strict observance of the "self-eliminating" regimen based upon the systolic pressure at the time of each dose. The late toxic reaction first appeared in March 1953. mm. Hg) during which time the blood pressure had gradually risen to systolic levels of 200 to 220 mm.; he had been troubled by some dyspnea on exertion and wheezing. Past history was significant in that he had "rheumatic fever" as a child and had since been told he had "leaky valves." He had been treated for anemia with iron pills and liver injections intermittently for three years. Investigation revealed severe hypertension with an average systolic pressure of 200 mm. Hg and a diastolic of 135 mm. Hg for one week in hospital. Response was poor during an amytal sedation test.
' .
There were no signs of cardiac decompensation and examination of the heart showed enlargement and an apical systolic murmur but no diastolic murmurs. The hemogram was normal. His kidneys concentrated the urine to a specific gravity of 1.021 and there was no albuminuria; excretion of phenol red was 20 per cent in 15 minutes. Electrocardiogram was compatible with left ventricular enlargement and myocardial damage.
Hydrazinophthalazine and hexamethonium (Hyphex) were begun in March 1952 with lowering of the pressure as shown in figure 1. For the next several months he felt well and continued to control his blood pressure, using gradually decreasing doses. In the fall of 1952 he first noticed occasional migratory joint pains and swelling of his wrists, elbows and ankles, which were never severe. In February 1953 he developed weakness, pallor and dyspnea on exertion. He was found by his physician to be anemic and he received iron and vitamin B1, without apparent change. On readmission, the average systolic pressure was 150 mm. and the diastolic 85. There was severe pallor and a purpuric area over the right ankle; no swelling of the joint, tenderness or deformity was present. Liver and spleen were not palpable and there was no adenopathy. Urine analysis showed 3-plus albuminuria with many red blood cells seen microscopically. The hemoglobin was 8.0 Gm. per 100 cc. with 2.7 million red cells per milliliter with normal indices. Chemical analysis revealed nonprotein nitrogen of the blood of 37 mg. per 100 cc.; total protein 6.0 Gm. per 100 cc. with albumin 3.7 Gm. and globulin 2.3 Gm. The excretion of phenol red was 12 per cent in 15 minutes. Erythroid stimulation was seen on bone marrow examination. Liver function tests showed a thymol turbidity of 8.0 units and a cephalin cholesterol flocculation of 4 plus. Antihypertensive drugs have been continued in reduced dosage.
Severe, but reversible reactions of "rheumatoid" arthritis were seen four times as illustrated by the following occurrence.
Case No. 3. B. R. was a 43 year old woman worker in a factory who was first seen in January 1952 for renal hypertension. Her systolic pressure was 180 mm. in 1945 and rose to 260 in 1950. One kidney had been removed for pyelonephritis in 1950 without effect. On examination her systolic pressure was 244 and her diastolic 130 mm. Hg. Nonprotein nitrogen in her blood was 46 mg. per 100 cc.; there was albuminuria and grade II retinopathy. She suffered a severe immediate reaction to 1-hydrazinophthalazine, which lasted several days, but her blood pressure was controlled from systolic levels of 240 and diastolic of 140 mm. Hg to normal.
Control was continuous and her dosage was gradually reduced. In October 1952, she became slowly incapacitated by severe arthritis involving all the joints of her extremities. In December she was given placebos similar to 1-hydrazinophthalazine and her arthritis slowly but only partly subsided. Through an error she was given the active agent and her joints became acutely inflamed but subsided when placebos were substituted. Through a second error she received 200 mg. of Apresoline; her body temperature rose to 41 C., her joints became acutely swollen, hot and painful, and she was readmitted to hospital acutely ill. The tip of her spleen was palpable. Her blood pressure remained at normal levels, controlled by small doses of hexamethonium chloride alone, and her joints improved. On three occasions she was given Apresoline, 1-4 dihydrazinophthalazine (Ba 7441) and 1 hydrazino-4-methyl phthalazine (Ba 6130). Shortly after each, her temperature rose, her joints became acutely swollen and tender, and she became prostrated. Small doses of cortisone controlled her arthritis, her blood pressure remained at reasonable levels and she was able to return to work without taking cortisone or Apresoline.
During the acute reactions, although there was no albuminuria, hematuria, anemia or leukopenia, there was generalized lymphadenopathy and hepatomegaly. Cephalin-cholesterol flocculation was three plus and thymol turbidity 8.7 units, with serum albumin of 3.7 and globulin of 3.0 Gm. per 100 cc.
FATAL REACTIONS IN COMBINED APRESOLINE
AND HEXAMETHONIUM (HYPHEX) Interstitial Pneumonia. On combined therapy, five deaths have occurred, caused apparently by pulmonary complications. Pathologically the findings were those of interstitial pneumonia.4* Because of the prevalence in this series of this otherwise rare condition, the drugs are strongly suspected of being causative factors. Four of the five were in Negroes; four * The condition was identical pathologically with "acute interstitial fibrosis of the lungs." Four of our cases, however, differed from those of Hamman and Rich4 and Rubin, Kahn, and Pecker,6 in that the disease was rapidly progressive to death within a week without development of cor pulmonale. Whether a virus infection superimposed upon pulmonary dynamics altered by hexamethonium ion, chemical irritation due to Apresoline, or the interaction of both agents on pulmonary tissue caused the disease is not known. The fact that we can add five cases to the 14 previously-collected6 implicates the combination of Apresoline and hexamethonium (Hyphex) as a direct or accessory cause. The prevalence in Negroes is curious. of the five were in men; three of the five patients who died had exhibited congestive heart failure; three of the five suffered from renal insufficiency and all had been in malignant stages of hypertension (table 5). The ratio of Negro to white patients in our series was 1:8.4; the ratio of males to females 1:1.4. The following report illustrates this condition.
Case No. 4. J. J. was a 33 year old Negro male office worker who had been discovered to have hypertension in 1943 while in the Army. After repeated determinations of his pressure, he was accepted for officers training and successfully completed two more years in the Army. He was given a routine discharge with no comment as to hypertension. In 1948 he was rejected as a Red Cross blood donor because of hypertension, but since he felt well, did not seek medical advice. In 1952 a medical examination was required to change his Civil Service status. Because of hypertension he was referred to an internist who found his blood pressure to be in excess of 220 mm. Hg systolic and 150 mm. diastolic on several occasions. Ocular fundi showed marked spasm and recent small hemorrhages. Albuminuria was also discovered for the first time.
On admission to hospital in September 1952 there was some reduction of blood pressure on bed rest to 200 mm. Hg systolic and 140 diastolic. Funduscopic examination showed no hemorrhages, exudates or papilledema. There was no evidence of cardiac failure and his general condition appeared good. A hemogram was normal. Examination of the urine confirmed the albuminuria. No growth appeared on urine culture. Intravenous pyelography showed no anatomical changes. Nonprotein nitrogen level of the blood was 25 mg. per 100 cc. Phenol red excretion was 15 per cent in 15 minutes. Radiography revealed that the heart was moderately enlarged and the lungs were clear. The electrocardiogram showed left ventricular enlargement.
Because of the markedly elevated pressure and previous observation of retinal hemorrhage this man was considered to be in a premalignant stage and therapy with Apresoline and hexamethonium (Hyphex) was begun. The initial response was disappointing and large doses of both hexamethonium chloride (4 to 6 Gm. daily) and 1-hydrazinophthalazine (1.2 Gm. daily) were required to reduce the average pressure to 160 systolic and 100 diastolic in hospital. He was continued on these doses for four months and moderately high serum levels of both agents were found. The blood pressure varied from 200 to 160 systolic and 130 to 100 diastolic.
In December 1952, he made a routine visit to the clinic and the respiratory rate was noted to be 80 per minute. He felt fairly well and aside from some difficulty in talking, he was able to carry on his usual activity. There was no evidence of cardiac decompensation and the lungs were clear on examination. Roentgenogram of the chest revealed extensive diffuse infiltration throughout both lung fields. The nonprotein nitrogen was 25 mg. per 100 cc. and the serum levels of hexamethonium chloride and 1-hydrazinophthalazine were not elevated. The tachypnea continued and on readmission to the hospital 48 hours later his respiratory rate was 90 per minute. Body temperature was 39 C. A few fine scattered rales could be heard over both lung fields. There was no hepatomegaly or dependent edema. Slight cyanosis was present. The circulation time was 20 seconds (arm to tongue) and the venous pressure 120 mm. H20. On chemical analysis the serum sodium was 137 mEq. per liter, the carbon dioxide capacity, 17 mEq. per liter and the pH of venous serum, 7.5. Pulmonary ventilation was markedly increased.
Treatment consisted of nasal oxygen, rest and intensive antibiotic therapy. His respiratory rate rose steadily and on the second hospital day reached 130 per minute. Cyanosis was minimal and did not seem to be altered by oxygen therapy although the patient felt that it helped. He seemed to become exhausted and died, seven days after the onset of symptoms. Tetany was never present. Two hours before death his systolic pressure was 190 and his diastolic 130 mm. Hg. Three other cases have been similar clinically in the rapid onset of symptoms and the downhill course lasting a week or less. In one Negro woman with severe renal damage the terminal course was gradual, consistent with that of uremia; only at autopsy was the pulmonary disturbance discovered. The only white man who developed this condition had had severe cardiac failure which had been well controlled. He was thought to suffer from acute lobar pneumonia and he died in the ambulance on the way to hospital. It is significant that in all cases observed, tachypnea and dyspnea were improved in the supine position.
Other Reactions. There have been five other deaths from nonhypertensive causes in patients in the malignant stage. One young Negro woman who did not control her dosage, and therefore her blood pressure, developed encephalopathy three times and lumbodorsal sympathectomy was advised. She succumbed to postoperative shock. Three have died at home of unknown causes but without recur-rence of hypertension. As previously stated, one man developed parotitis and pneumonia from which he died.
Two deaths may be ascribed to the injudicious use of these drugs. In one young woman with encephalopathy and uremia both agents were given parenterally within a few hours of each other; a profound fall of pressure to shock levels required infusion of norepinephrine. When her blood pressure rose to previous levels after four days, pulmonary edema developed and she died. Multiple small myocardial infarcts were present at autopsy. In another hospital, placebos were substituted for the drugs after good control had been established in a case known to us. Blood pressure rose. The placebos were later replaced by full doses of the active drugs and one-half hour after the first dose the patient died suddenly. No autopsy was done.
DISCUSSION
The total incidence of fatalities in patients adequately treated with combined Apresoline and hexamethonium (Hyphex) but due to hypertensive causes (cerebral vascular accident, coronary occlusion, developing renal insufficiency) was 1.3 per cent and not caused by hypertensive complications, 7.6 per cent. Although all of the latter deaths were in patients with malignant hypertension, the gross incidence is excessive for any good therapeutic procedure. From another viewpoint, the incidence of interstitial pneumonia probably induced by therapy with Apresoline and hexamethonium (Hyphex) was 5.6 per cent in malignant hypertension (89 cases), 29.4 per cent in malignant hypertensive Negroes (17 cases), 37.5 per cent in hypertensive Negro men (8 cases) and 50 per cent in malignant hypertensive Negro men (6 cases), based on a small series. This incidence is excessive. We are at a loss to explain it. A new disease has apparently been produced by exogenous chemical agents (ontilluously introduced into the body.
The five deaths due to nonhypertensive causes were not! surprising, considering the degree of vascular damage already present.
Pneumonia following parotitis in an elderly man with renal insufficiency who had suffered complete hemiplegia, postoperative shock in a young woman with severe malignant hypertension, and sudden deaths in three patients with chronic congestive heart failure and renal insufficiency are to be expected in any series of patients with severe debilitating and fatal diseases. That they died normotensive does not necessarily implicate the drugs as causes.
More disturbing, however, is the incidence of late reactions induced by 1-hydrazinophthalazine, notably "collagen" disease with arthritis, resembling disseminated lupus erythematosus. The incidence, again, is excessive (7.2 per cent) and will undoubtedly increase. We do not believe that rheumatoid arthritis developed by chance in these individuals, for the condition was exacerbated by the drug. It represents rather, the production of a new condition by a new agent and is better explained as a phenomenon of depletion rather than as one of hypersensitivity.2 Because of these complications, the use of combined Apresoline and hexamethonium (Hyphex) might be restricted were it not for the almost uniformly fatal nature of malignant hypertension, to which interstitial pneumonia has been confined, and the relatively benign nature of the arthritis. The drugs incontrovertibly prolong life in malignant hypertension, and "irreversible" or fatal late reactions have occurred in only one of 97 white males. Therefore, for the present, the risk appears warranted in white persons who would otherwise deteriorate rapidly. Likewise, in all persons with severe benign hypertension no "irreversible" reaction has occurred.
The prompt appearance of fever in six cases starting therapy with 1-hydrazinophthalazine was considered a less serious reaction. Early recognition of the febrile response and appropriate reduction or omission of dosage alleviated the symptoms. Individuals developing a specific untoward reaction to 1-hydrazinophthalazine all exhibited an increased hypotensive effect. This correlation of antihypertensive activity and toxic response suggests that both may be manifestations of a single fundamental metabolic action. In a total of 11 persons (4.2 per cent) it was considered impossible or unwise to continue 1-hydrazinophthalazine because of untoward response. In an additional four persons (1.6 per cent) who developed reactions, it was possible to continue the drug. No evidence of suppression of bone marrow activity has been discovered. The drug in combination with sympatholysis is an effective antihypertensive agent, but its use is not without hazard.
Hexamethonium salts, while good antihypertensive agents, are imperfect because of their wide range of effects resulting from diffuse autonomic blockade. In our series, all of the unwanted responses could be related to this action. Fortunately most reactions were mild, many were transient, and all couAd be specifically treated. Serious effects of autonomic paralysis occurred only in the presence of complicating organic disease, as observed in 25 patients. In only two (0.8 per cent) was it necessary to discontinue the drug. Although methonium compounds with a longer carbon chain produce a "curariform" effect, or neuromuscular blockade, this action has not been observed with hexamethonium salts. No specific sensitivity to hexamethonium compounds was encountered, which confirms earlier observations in both animals and human beings.5 The oral form of the drug is safe to use in the absence of uremia, provided constipation is prevented and each dose is reduced or omitted when the blood pressure is normal.2 Ideal drugs for use in the chronic therapy of hypertension are those whose pharmacologic action favorably affects the mechanisms of hypertension without auxiliary action or capacity for inducing hypersensitivity. Neither of these agents can be considered ideal. Hexamethonium ion causes widespread minor alteration of function not desirable for the control of hypertension, while 1-hydrazinophthalazine is capable of inducing serious late reactions.
SUMMARY AND CONCLUSIONS
Experience gained in the observation of 258 cases of hypertension treated for 6 to 25 months with combined Apresoline and hexamethonium (Hyphex) is reported with relation to the un-toward reactions encountered. Minor reactions and side effects to one or both agents were seen in most cases.
Fatal complications were observed in the form of interstitial pneumonia in five cases, uncontrolled hypotension in one and sudden death in one. 1-Hydrazinophthalazine apparently caused arthritis and "collagein-like" disease in 16, and repeated febrile responses in six. Serious obstructive phenomena due to hexamethonium chloride in previous organic obstruction occurred in 10 cases. Of the 44 cases with reactions (17 per cent), eight (3 per cent) were fatal, five due to interstitial pneumonia, one due to pneumonia following parotitis, and two due to simultaneous administration of both drugs.
In spite of reactions and side effects, the combined use of both agents is ati effective and practical method of treating severe hypertension provided precautions are taken to minimize serious consequences, for the benefits observed clearly have outweighed the risks. Neither agent, however, is ideal. ADDENDUM Since this paper was submitted for publication, a report on the treatment of hypertension by hexamethonium ion in 39 individuals was published by Morrison.7 Three patients with malignant hypertension, two of whom exhibited congestive heart failure and one nitrogen retention, developed bilateral pulmonary opacities and severe dyspnea, relieved in the supine position. One died and at autopsy showed pulmonary lesions not positively identified in a preliminary report but suggestive of those here considered as acute interstitial pneumonia. That this disease occurred in patients taking hexamethonium ion alone tends to incriminate this drug as the causative agent in our cases and not the combined therapy.
SUMARIO ESPAROL
Aunque el hexamethonium y 1-hydrazinophthalazine son efectivos en mantener presiones arteriales relativamente normales en pacientes hipertensos y retardan algunias de las consequencias serias de la enfermedad, tambie'n pueden producir reacciones serias inmedia-tas y tardias. La uiltima droga ha producido enfermedades colagenas de grados variables de intensidad, todas las cuales han tendido a desaparecer con cesacion del medicamento, en 14 de 253 pacientes. La combinacion ha producido pulmonfia intersticial fatal en 5 de 89 casos de hipertension en el estado maligno. Algunos efectos no deseables menos serios de cada droga tambien se discuten.
